Celadon Pharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$764K
- Investors
-
2
Celadon Pharmaceuticals General Information
Description
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.
Contact Information
Website
www.celadonpharma.comCorporate Office
- 71-75 Shelton Street
- London WC2H 9JQ
- England, United Kingdom
Corporate Office
- 71-75 Shelton Street
- London WC2H 9JQ
- England, United Kingdom
Celadon Pharmaceuticals Timeline
Celadon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. PIPE | 15-Jul-2024 | $764K | Completed | Generating Revenue | ||
| 4. PIPE | 12-Dec-2023 | Completed | Generating Revenue | |||
| 3. PIPE | 13-Oct-2023 | Completed | Generating Revenue | |||
| 2. PIPE | 25-Mar-2022 | $11.2M | $11.2M | Completed | Generating Revenue | |
| 1. Reverse Merger | 25-Mar-2022 | $106M | Completed | Generating Revenue |
Celadon Pharmaceuticals Patents
Celadon Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202417688-D0 | Novel process | Pending | 02-Dec-2024 |
Celadon Pharmaceuticals Signals
Celadon Pharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Celadon Pharmaceuticals (Acquired in 2022) | Corporation | Minority | ||
| Seneca Partners (Haydock) | Real Estate | Minority |
Celadon Pharmaceuticals Investments & Acquisitions (3)
Celadon Pharmaceuticals’s most recent deal was a Early Stage VC with Kingdom Therapeutics for . The deal was made on 07-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kingdom Therapeutics | 07-Jul-2023 | Early Stage VC | Drug Discovery | ||
| Celadon Pharmaceuticals (Acquired in 2022) | 25-Mar-2022 | Merger/Acquisition | Other Capital Markets/Institutions | ||
| Kingdom Therapeutics | 07-Jun-2021 | Seed Round | Drug Discovery |
Celadon Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Food Products
Industry
Rank
Percentile
Agriculture
Subindustry
Rank
Percentile
Celadon Pharmaceuticals FAQs
-
When was Celadon Pharmaceuticals founded?
Celadon Pharmaceuticals was founded in 2018.
-
Where is Celadon Pharmaceuticals headquartered?
Celadon Pharmaceuticals is headquartered in London, United Kingdom.
-
What is the size of Celadon Pharmaceuticals?
Celadon Pharmaceuticals has 19 total employees.
-
What industry is Celadon Pharmaceuticals in?
Celadon Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Celadon Pharmaceuticals a private or public company?
Celadon Pharmaceuticals is a Private company.
-
What is Celadon Pharmaceuticals’s current revenue?
The current revenue for Celadon Pharmaceuticals is .
-
How much funding has Celadon Pharmaceuticals raised over time?
Celadon Pharmaceuticals has raised $15.7M.
-
Who are Celadon Pharmaceuticals’s investors?
Celadon Pharmaceuticals (Acquired in 2022) and Seneca Partners (Haydock) have invested in Celadon Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process